期刊
IUBMB LIFE
卷 61, 期 11, 页码 1063-1074出版社
WILEY
DOI: 10.1002/iub.262
关键词
disease models; drug discovery; genetics; glycobiology
资金
- NIH [5 R01 HD054744-02, 1 R03 MH085689-01]
In most organisms, productive utilization of galactose requires the highly conserved Leloir pathway of galactose metabolism. Yet, if this metabolic pathway is perturbed due to congenital deficiencies of the three associated enzymes, or an overwhelming presence of galactose, this monosaccharide which is abundantly present in milk and many non-dairy foodstuffs, will become highly toxic to humans and animals. Despite more than four decades of intense research, little is known about the molecular mechanisms of galactose toxicity in human patients and animal models. In this contemporary review, we take a unique approach to present an overview of galactose toxicity resulting from the three known congenital disorders of galactose metabolism and from experimental hypergalactosemia. Additionally, we update the reader about research progress on animal models, as well as advances in clinical management and therapies of these disorders. (C) 2009 IUBMB IUBMB Life, 61(11): 1063-10741, 2009
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据